1. Get the Diabetes Forum App for your phone - available on iOS and Android.
    Dismiss Notice
  2. Guest, we'd love to know what you think about the forum! Take the Diabetes Forum Survey 2021 »
    Dismiss Notice
  3. Diabetes Forum should not be used in an emergency and does not replace your healthcare professional relationship. Posts can be seen by the public.
    Dismiss Notice
  4. Guest, stay home, stay safe, save the NHS. Stay up to date with information about keeping yourself and people around you safe here and GOV.UK: Coronavirus (COVID-19). Think you have symptoms? NHS 111 service is available here.
    Dismiss Notice
Dismiss Notice
Find support, ask questions and share your experiences. Join the community »

Insulin shortage could affect 50,000 people with diabetes in the UK

Discussion in 'Diabetes News' started by DCUK NewsBot, Dec 23, 2015.

  1. DCUK NewsBot

    DCUK NewsBot · Well-Known Member

    Likes Received:
    Trophy Points:
    As many as 50,000 people with diabetes may need to be switched to alternative insulin injections, with supplies of certain insulin products running out fast. Sanofi, the manufacturer of the products in short supply, warned that missing out on insulin treatment can be "life-threatening." Affected products include Sanofi's Insuman Basal 100IU/mL, Insuman Comb 25 100 IU/mL cartridges, and Insuman Basal Solostar 100 IU/mL and Insuman Comb 25 Solostar prefilled pens. Although there will be some stock, supplies could be very limited for the next eight months. Sanofi stated in a letter to the NHS that there could be a "supply shortage in the United Kingdom of some Insuman presentations (recombinant human insulin) from 1 December 2015." The problem, they explained, was due to "limited capacity at the manufacturing site [...] supply is expected to return to normal in July 2016." Many of the 50,000 people treated with this insulin are being switched to alternative insulin injections. For people with type 1 diabetes, going without insulin is simply not an option; a fact recognised in Sanofi's letter. "Interruption of insulin treatment is potentially life-threatening. Therefore replacement with alternative insulin formations is needed to avoid hyperglycemia and serious complications." People on Insuman Basal preparations will be switched to Humulin I and Insulatard. People using Comb 25 products will switch to Humulin M3. Sanofi has retained a small supply of Insuman Basal preparations that will be prescribed on a case-by-case basis. Insuman is one of many drug shortages affecting the NHS at this time of year. It may, however, be one of the most problematic, because it isn't possible to switch to a like-for-like insulin. Doctors will have to work with their patients to make the switch to other forms of insulin safe. "[A] simple switch to an alternative is not possible, and most patients will need input to manage the change safely," said Dr. Andrew Green, chair of the GPC clinical and prescribing subcommittee.

    Continue reading...
  • Meet the Community

    Find support, connect with others, ask questions and share your experiences with people with diabetes, their carers and family.

    Did you know: 7 out of 10 people improve their understanding of diabetes within 6 months of being a Diabetes Forum member. Get the Diabetes Forum App and stay connected on iOS and Android

    Grab the app!
  • Tweet with us

  • Like us on Facebook